Soluble antibodies play immune suppressive role in tumor progression

April 12, 2018, The Wistar Institute
Dr. Andrew Hu in the lab Credit: The Wistar Institute

Wistar researchers have found that soluble antibodies promote tumor progression by inducing accumulation of myeloid-derived suppressor cells (MDSCs) in pre-clinical cancer models. Results were published online in Cancer Immunology Research.

Chronic lymphocytic leukemia (CLL) is a malignancy characterized by the progressive accumulation of mature B . Several reports indicated that B cells can mediate immune suppression and negatively affect the antitumor immune response in several types. This research, led by Chih-Chi Andrew Hu, Ph.D., associate professor in Wistar's Immunology, Microenvironment & Metastasis Program, and colleagues, used CLL and lung cancer mouse models to better define the role of soluble antibodies produced by B cells in orchestrating the immune suppressive response.

"Our research highlights the contribution of soluble antibodies in inducing accumulation of MDSCs," said Hu. "These are a population of that inhibit the antitumor functions of T cells and cause worse outcomes in many cancer types."

Through elegant crossing experiments, the researchers generated a mouse model of CLL in which malignant B cells produced abundant amounts of soluble antibodies, whereas CLL cells were considered to produce primarily membrane-bound antigen receptors. As a result, the mice developed significantly increased numbers of a specific cell population in the blood, which the researchers characterized as MDSCs.

To examine the role of soluble antibodies in the accumulation of MDSCs, they included an additional model of CLL in which B cells can only produce membrane-bound antigen receptors but not soluble antibodies. Survival was longer and there was a significantly lower number of MDSCs, which also had lower ability to suppress T cells, thus suggesting that soluble antibodies are responsible for accumulation of immune suppressive MDSCs.

Impairing the synthesis of soluble antibodies in tumor-bearing mice may be useful to slow down , according to Hu. In fact, genetic and pharmacological targeting of the IRE-1/XBP-1 pathway of the endoplasmic reticulum stress response, which is critical for antibody production, results in decreased numbers and reduced functions of MDSCs. Hu and his collaborator Juan R. Del Valle at the University of South Florida are developing novel small molecule inhibitors against IRE-1 to combat cancers associated with high numbers of MDSCs.

The researchers expanded the relevance of these findings to lung carcinoma, showing that soluble antibodies are generally important in the tumor microenvironment to induce accumulation of MDSCs and promote cancer progression.

"We suggest that soluble antibodies may execute their immune suppressive function by recruiting MDSCs in the tumor microenvironment or promoting their functions", said Chih-Hang Anthony Tang, M.D., Ph.D., a staff scientist in the Hu Lab and the first author of the study. "Another possibility is that soluble may stimulate other types of to produce soluble factors that in turn contribute to the expansion of MDSCs and their functions."

Explore further: Immunosuppressive cells in newborns play important role in controlling inflammation in early life

Related Stories

Immunosuppressive cells in newborns play important role in controlling inflammation in early life

January 15, 2018
New research led by The Wistar Institute, in collaboration with Sun Yat-sen University in China, has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing ...

Scientists identify marker for myeloid-derived suppressor cells

August 5, 2016
Myeloid-derived suppressor cells (MDSCs) are a population of immune cells that have been implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy. Polymorphonuclear ...

Cellular network identified that 'short circuits' the antitumor effect of immunotherapies

November 13, 2017
Researchers from The Wistar Institute discovered a novel form of crosstalk among tumor cells and other cell types in the tumor microenvironment, elucidating the mechanism of action of an immunotherapeutic strategy that inhibits ...

Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor

May 16, 2016
Not every breast cancer tumor follows the same path to grow. Some tumors have the assistance of myeloid-derived suppressor cells (MDSCs), a diverse type of immune cell involved in the suppression of the body's response against ...

Immune suppressor cells identified for advanced prostate cancer

December 21, 2015
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.

Can myeloid derived suppressor cells subdue viral infections?

January 26, 2017
Myeloid derived suppressor cells (MDSCs), produced in the bone marrow as part of the human immune response to a tumor, may have a potent immunoregulatory role following viral infection. The similarities and differences between ...

Recommended for you

Student develops microfluidics device to help scientists identify early genetic markers of cancer

October 16, 2018
As anyone who has played "Where's Waldo" knows, searching for a single item in a landscape filled with a mélange of characters and objects can be a challenge. Chrissy O'Keefe, a Ph.D. student in the Department of Biomedical ...

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Technique to 'listen' to a patient's brain during tumour surgery

October 16, 2018
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

October 16, 2018
Squamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophagus, head and neck, lungs, and skin. Previous studies have demonstrated that two master ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.